Triple
T4784933
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | REGN-EB3 |
E106452
|
entity |
| Predicate | clinicalTrialOutcome |
P47971
|
FINISHED |
| Object | significant reduction in death compared with control therapy |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: significant reduction in death compared with control therapy | Statement: [REGN-EB3, clinicalTrialOutcome, significant reduction in death compared with control therapy]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: clinicalTrialOutcome Context triple: [REGN-EB3, clinicalTrialOutcome, significant reduction in death compared with control therapy]
-
A.
outcomeOfTrial
chosen
Indicates that a particular result or verdict is produced as the consequence of a specific trial or legal proceeding.
-
B.
coordinatesClinicalTrialsFor
Indicates that one entity organizes, manages, or oversees the planning and execution of clinical trials on behalf of another entity.
-
C.
initialOutcome
Indicates the result or state that first occurs at the beginning of a process, event, or interaction, before any subsequent changes or outcomes.
-
D.
trialDesign
Indicates the specific structure, methodology, and procedural plan according to which a trial or experiment is conducted.
-
E.
hasKeyClinicalTrial
Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43f4a9588190bf73e20bc27c03cc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd65ae49ec81908f16248d22d1155f |
completed | March 20, 2026, 3:20 p.m. |
| PD | Predicate disambiguation | batch_69bd622e1b408190806c15c61519fc74 |
completed | March 20, 2026, 3:05 p.m. |
Created at: March 20, 2026, 1:22 p.m.